SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-229278
Filing Date
2020-08-25
Accepted
2020-08-25 09:02:02
Documents
13
Period of Report
2020-08-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d89886d8k.htm   iXBRL 8-K 28750
2 EX-99.1 d89886dex991.htm EX-99.1 9618
  Complete submission text file 0001193125-20-229278.txt   166225

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20200824.xsd EX-101.SCH 3082
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200824_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200824_pre.xml EX-101.PRE 11416
6 EXTRACTED XBRL INSTANCE DOCUMENT d89886d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 201129656
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences